Profile - To The Moon

bhahab

Posts · 610Posts · 610
Following · 0Following · 0
Followers · 0Followers · 0

- bhahabbhahab
  ·03-31
  $Amazon.com(AMZN)$ cc
  303 Comment
  2
  Share
  Report
- bhahabbhahab
  ·2022-05-31
  $Apple(AAPL)$g
  321 Comment
  1
  Share
  Report
- bhahabbhahab
  ·2022-05-31
  $Apple(AAPL)$gg
  462 Comment
  Like
  Share
  Report
- bhahabbhahab
  ·2022-05-25
  $Oatly Group AB(OTLY)$ff
  339 Comment
  1
  Share
  Report
- bhahabbhahab
  ·2022-05-25
  $Apple(AAPL)$ff
  473 Comment
  1
  Share
  Report
- bhahabbhahab
  ·2022-05-19
  $Apple(AAPL)$gg
  472 Comment
  Like
  Share
  Report
- bhahabbhahab
  ·2022-05-19
  $Walt Disney(DIS)$g
  469 Comment
  Like
  Share
  Report
- bhahabbhahab
  ·2022-05-19
  G
  3 of the Smartest Stocks to Buy in a Fed-Induced Bear Market
  A plunging stock market is the ideal time to put your money to work in these time-tested companies.
  3 of the Smartest Stocks to Buy in a Fed-Induced Bear Market
  395 Comment
  5
  Share
  Report
- bhahabbhahab
  ·2022-05-16
  $Apple(AAPL)$f
  443 Comment
  Like
  Share
  Report
- bhahabbhahab
  ·2022-05-16
  G
  2 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget
  Buying these stocks on the dip could result in big returns for investors.
  2 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget
  632 Comment
  3
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3581814406562580","uuid":"3581814406562580","gmtCreate":1618752358445,"gmtModify":1704447496807,"name":"bhahab","pinyin":"bhahab","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":93,"headSize":483,"tweetSize":610,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.05","exceedPercentage":"60.86%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.29","exceedPercentage":"60.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":12,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":290236093964464,"gmtCreate":1711864966618,"gmtModify":1711864971442,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AMZN\">$Amazon.com(AMZN)$ </a> cc","listText":"<a href=\"https://ttm.financial/S/AMZN\">$Amazon.com(AMZN)$ </a> cc","text":"$Amazon.com(AMZN)$ cc","images":[{"img":"https://community-static.tradeup.com/news/46a0e99e397cb2fb95a67507762721a4","width":"906","height":"1406"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/290236093964464","isVote":1,"tweetType":1,"viewCount":303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9024765966,"gmtCreate":1653927887155,"gmtModify":1676535363911,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>g","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>g","text":"$Apple(AAPL)$g","images":[{"img":"https://community-static.tradeup.com/news/0a8b4dc80cc4afafa4bc55cfa6036b5b","width":"1080","height":"3501"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9024765966","isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9024765084,"gmtCreate":1653927866048,"gmtModify":1676535363932,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>gg","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>gg","text":"$Apple(AAPL)$gg","images":[{"img":"https://community-static.tradeup.com/news/2fa03305b66315b5dc5642434cfc07c7","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9024765084","isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9022122393,"gmtCreate":1653493776812,"gmtModify":1676535292234,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/OTLY\">$Oatly Group AB(OTLY)$</a>ff","listText":"<a href=\"https://ttm.financial/S/OTLY\">$Oatly Group AB(OTLY)$</a>ff","text":"$Oatly Group AB(OTLY)$ff","images":[{"img":"https://community-static.tradeup.com/news/fa70e9cd122a5314e82f54169d8041ad","width":"1080","height":"3525"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022122393","isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9022122938,"gmtCreate":1653493766524,"gmtModify":1676535292233,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>ff","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>ff","text":"$Apple(AAPL)$ff","images":[{"img":"https://community-static.tradeup.com/news/d6bba9ef46cb5fca103967cfb9c6fcbc","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022122938","isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9021030685,"gmtCreate":1652971989647,"gmtModify":1676535199350,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>gg","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>gg","text":"$Apple(AAPL)$gg","images":[{"img":"https://community-static.tradeup.com/news/da20a331b823fdeae86491522d75f2eb","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9021030685","isVote":1,"tweetType":1,"viewCount":472,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9021030302,"gmtCreate":1652971978606,"gmtModify":1676535199336,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/DIS\">$Walt Disney(DIS)$</a>g","listText":"<a href=\"https://ttm.financial/S/DIS\">$Walt Disney(DIS)$</a>g","text":"$Walt Disney(DIS)$g","images":[{"img":"https://community-static.tradeup.com/news/ab2c7e4ebf262ccd0a80140c110da70c","width":"1080","height":"3402"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9021030302","isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9021097772,"gmtCreate":1652971953796,"gmtModify":1676535199312,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"G","listText":"G","text":"G","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9021097772","repostId":"2236775163","repostType":4,"repost":{"id":"2236775163","pubTimestamp":1652965746,"share":"https://ttm.financial/m/news/2236775163?lang=&edition=fundamental","pubTime":"2022-05-19 21:09","market":"us","language":"en","title":"3 of the Smartest Stocks to Buy in a Fed-Induced Bear Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2236775163","media":"Motley Fool","summary":"A plunging stock market is the ideal time to put your money to work in these time-tested companies.","content":"<html><head></head><body><p>Last year, things couldn&#39;t have gone more swimmingly for the stock market. The Federal Reserve was intent on maintaining its dovish monetary stance, and historically low interest rates were fueling hiring, acquisitions, and innovation throughout the tech sector.</p><p>But, oh, what a difference a year can make!</p><p>Last week, the U.S. Bureau of Labor Statistics reported that the trailing-12-month inflation rate hit 8.3% in April, which is just a hair below its 40-year high. Although some aspects of inflation have been out of the Federal Reserve&#39;s control (e.g., Russia invading Ukraine), hindsight has demonstrated that the nation&#39;s central bank left its foot on the accelerator for far too long. Keeping interest rates near historic lows for years -- including purchasing long-term bonds via quantitative easing -- looks to be a key reason the <b>Nasdaq Composite</b> has lost more than a quarter of its value and pushed firmly into a bear market.</p><p>But if there&#39;s a silver lining in the stock market&#39;s struggles, it&#39;s that fear historically breeds opportunity for patient investors. Every single notable decline throughout history has eventually been erased by a bull market rally.</p><p>What follows are three of the smartest stocks investors can buy in a Fed-induced bear market.</p><h2>NextEra Energy</h2><p>The first genius buy in a Fed-driven bear market is the nation&#39;s largest electric utility stock, <b>NextEra Energy</b>.</p><p>First and foremost, electric utility stocks provide a basic necessity service. If you own or rent a home, there&#39;s a very good chance you need electricity to power the appliances in your home. Demand for electricity doesn&#39;t change much from <a href=\"https://laohu8.com/S/AONE.U\">one</a> year to the next, which leads to highly predictable cash flow for utility companies. This cash flow transparency is what allows a company like NextEra to set aside capital for new infrastructure projects and acquisitions without adversely impacting its profitability or dividend.</p><p>What really sets NextEra apart from its competition (why it has such a large market cap relative to other utility providers) is its focus on renewable energy projects. No utility is generating more capacity from wind or solar power than NextEra -- and that&#39;s unlikely to change anytime soon. The company has pledged up to $55 billion in spending on infrastructure projects between 2020 and 2022. What&#39;s more, Energy Resources, the renewable energy arm of NextEra Energy, expects its renewable energy and storage projects to total between 22,675 megawatts (MW) and 30,0000 MW between 2021 and 2024.</p><p>Although renewable energy projects can be pricy, and NextEra&#39;s management team is likely disappointed that borrowing rates are climbing, these investments are well worth it. Not only is NextEra Energy staying ahead of potential green-energy policy changes from Capitol Hill, but it&#39;s also significantly lowering its electricity generation costs. As a result, NextEra has consistently grown by a high-single-digit percentage for more than a decade. That compares to low-single-digit growth for much of the utility sector.</p><p>Considering that NextEra has delivered a positive total return, including dividends, to its shareholders in 19 of the past 20 years, it&#39;s a smart buy in an unsettled market.</p><h2><a href=\"https://laohu8.com/S/ARLP\">Alliance Resource Partners</a></h2><p>Another really smart stock to buy in a Fed-induced bear market is coal producer <b>Alliance Resource Partners</b>.</p><p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> years ago, the previous sentence would have been a ridiculous statement. During the initial stages of the pandemic, coal demand and per-ton pricing slumped, which exposed coal producers with leveraged balance sheets. Thankfully, Alliance Resource Partners wasn&#39;t among them. However, demand weakness and uncertainty tied to COVID-19 did force the company to forgo its dividend for a year.</p><p>But things have changed drastically since spring 2020. The per-ton price for coal has increased by 137% just since the beginning of 2022, and has jumped roughly eightfold since the 2020 low.  With most energy companies unable to aggressively invest in infrastructure during the pandemic, supply chain constraints are expected to keep coal prices elevated for the foreseeable future.</p><p>What investors will appreciate about Alliance Resource Partners is the company&#39;s ability to lock in volume and price commitments well in advance. According to the company&#39;s first-quarter report, over 90% its forecast 35.5 million tons to 37 million tons are already locked in for 2022. Further, 19.9 million tons of production are committed and locked in on price for 2023. This is a company that regularly commits production three to four years out to sustain transparent cash flow.</p><p>Alliance Resource Partners also has oil and natural gas royalties that should benefit the company for years to come. With crude oil and natural gas hitting multidecade highs, the company can expect a big uptick in royalty-based adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).</p><p>If you need one more reason to trust in Alliance Resource Partners, consider this: Its supercharged dividend is back! The company is currently paying out a 7.4% yield and anticipates increasing its quarterly distribution by 10% to 15% <i>per quarter</i> through the rest of 2022.</p><h2>Vertex Pharmaceuticals</h2><p>The third smart stock to scoop up during this Fed-driven bear market is specialty biotech company <b>Vertex Pharmaceuticals</b>.</p><p>The beauty of healthcare stocks is that they&#39;re highly defensive. No matter how well or poorly the stock market performs, people can&#39;t control when they get sick or what ailment(s) they develop. This creates a base level of demand that drugmakers, medical device companies, and healthcare service providers can expect in any economic environment.</p><p>The differentiating factor that makes Vertex Pharmaceuticals special is its focus on treating patients with cystic fibrosis (CF). CF is a genetic disease with no cure that&#39;s characterized by thick mucus production, which can obstruct a patients&#39; lungs and/or pancreas.</p><p>To date, Vertex has developed four generations of mutation-specific CF therapies that work to improve lung function -- and it&#39;s currently working on its next-gen treatment. The company&#39;s most recently approved CF therapy, Trikafta, was given the green light five months prior to its scheduled Food and Drug Administration review date, and is on pace to generate $7 billion in sales this year.</p><p>Beyond its CF treasure trove, Vertex has more than a half-dozen compounds in development. While some of these therapies are being developed internally, others, such as CTX001 for beta thalassemia and sickle cell disease, are partnered projects. Given Vertex&#39;s solid drug-development track record, there&#39;s a good chance at least some of these treatments will reach pharmacy shelves.</p><p>A final reason to be excited about Vertex is the company&#39;s cash-rich balance sheet. Sporting $8.24 billion in cash, cash equivalents, and marketable securities (and no debt), the company has ample capital to continue its research and perhaps even do some shopping of its own.</p><p>With north of $15 per share in earnings forecast by Wall Street in 2023, Vertex has shown no signs of slowing down.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 of the Smartest Stocks to Buy in a Fed-Induced Bear Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 of the Smartest Stocks to Buy in a Fed-Induced Bear Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-19 21:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/05/19/3-smartest-stocks-buy-in-a-fed-induced-bear-market/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last year, things couldn't have gone more swimmingly for the stock market. The Federal Reserve was intent on maintaining its dovish monetary stance, and historically low interest rates were fueling ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/19/3-smartest-stocks-buy-in-a-fed-induced-bear-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NEE":"新纪元能源","ARLP":"Alliance Resource Partners","VRTX":"福泰制药"},"source_url":"https://www.fool.com/investing/2022/05/19/3-smartest-stocks-buy-in-a-fed-induced-bear-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2236775163","content_text":"Last year, things couldn't have gone more swimmingly for the stock market. The Federal Reserve was intent on maintaining its dovish monetary stance, and historically low interest rates were fueling hiring, acquisitions, and innovation throughout the tech sector.But, oh, what a difference a year can make!Last week, the U.S. Bureau of Labor Statistics reported that the trailing-12-month inflation rate hit 8.3% in April, which is just a hair below its 40-year high. Although some aspects of inflation have been out of the Federal Reserve's control (e.g., Russia invading Ukraine), hindsight has demonstrated that the nation's central bank left its foot on the accelerator for far too long. Keeping interest rates near historic lows for years -- including purchasing long-term bonds via quantitative easing -- looks to be a key reason the Nasdaq Composite has lost more than a quarter of its value and pushed firmly into a bear market.But if there's a silver lining in the stock market's struggles, it's that fear historically breeds opportunity for patient investors. Every single notable decline throughout history has eventually been erased by a bull market rally.What follows are three of the smartest stocks investors can buy in a Fed-induced bear market.NextEra EnergyThe first genius buy in a Fed-driven bear market is the nation's largest electric utility stock, NextEra Energy.First and foremost, electric utility stocks provide a basic necessity service. If you own or rent a home, there's a very good chance you need electricity to power the appliances in your home. Demand for electricity doesn't change much from one year to the next, which leads to highly predictable cash flow for utility companies. This cash flow transparency is what allows a company like NextEra to set aside capital for new infrastructure projects and acquisitions without adversely impacting its profitability or dividend.What really sets NextEra apart from its competition (why it has such a large market cap relative to other utility providers) is its focus on renewable energy projects. No utility is generating more capacity from wind or solar power than NextEra -- and that's unlikely to change anytime soon. The company has pledged up to $55 billion in spending on infrastructure projects between 2020 and 2022. What's more, Energy Resources, the renewable energy arm of NextEra Energy, expects its renewable energy and storage projects to total between 22,675 megawatts (MW) and 30,0000 MW between 2021 and 2024.Although renewable energy projects can be pricy, and NextEra's management team is likely disappointed that borrowing rates are climbing, these investments are well worth it. Not only is NextEra Energy staying ahead of potential green-energy policy changes from Capitol Hill, but it's also significantly lowering its electricity generation costs. As a result, NextEra has consistently grown by a high-single-digit percentage for more than a decade. That compares to low-single-digit growth for much of the utility sector.Considering that NextEra has delivered a positive total return, including dividends, to its shareholders in 19 of the past 20 years, it's a smart buy in an unsettled market.Alliance Resource PartnersAnother really smart stock to buy in a Fed-induced bear market is coal producer Alliance Resource Partners.Two years ago, the previous sentence would have been a ridiculous statement. During the initial stages of the pandemic, coal demand and per-ton pricing slumped, which exposed coal producers with leveraged balance sheets. Thankfully, Alliance Resource Partners wasn't among them. However, demand weakness and uncertainty tied to COVID-19 did force the company to forgo its dividend for a year.But things have changed drastically since spring 2020. The per-ton price for coal has increased by 137% just since the beginning of 2022, and has jumped roughly eightfold since the 2020 low.  With most energy companies unable to aggressively invest in infrastructure during the pandemic, supply chain constraints are expected to keep coal prices elevated for the foreseeable future.What investors will appreciate about Alliance Resource Partners is the company's ability to lock in volume and price commitments well in advance. According to the company's first-quarter report, over 90% its forecast 35.5 million tons to 37 million tons are already locked in for 2022. Further, 19.9 million tons of production are committed and locked in on price for 2023. This is a company that regularly commits production three to four years out to sustain transparent cash flow.Alliance Resource Partners also has oil and natural gas royalties that should benefit the company for years to come. With crude oil and natural gas hitting multidecade highs, the company can expect a big uptick in royalty-based adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA).If you need one more reason to trust in Alliance Resource Partners, consider this: Its supercharged dividend is back! The company is currently paying out a 7.4% yield and anticipates increasing its quarterly distribution by 10% to 15% per quarter through the rest of 2022.Vertex PharmaceuticalsThe third smart stock to scoop up during this Fed-driven bear market is specialty biotech company Vertex Pharmaceuticals.The beauty of healthcare stocks is that they're highly defensive. No matter how well or poorly the stock market performs, people can't control when they get sick or what ailment(s) they develop. This creates a base level of demand that drugmakers, medical device companies, and healthcare service providers can expect in any economic environment.The differentiating factor that makes Vertex Pharmaceuticals special is its focus on treating patients with cystic fibrosis (CF). CF is a genetic disease with no cure that's characterized by thick mucus production, which can obstruct a patients' lungs and/or pancreas.To date, Vertex has developed four generations of mutation-specific CF therapies that work to improve lung function -- and it's currently working on its next-gen treatment. The company's most recently approved CF therapy, Trikafta, was given the green light five months prior to its scheduled Food and Drug Administration review date, and is on pace to generate $7 billion in sales this year.Beyond its CF treasure trove, Vertex has more than a half-dozen compounds in development. While some of these therapies are being developed internally, others, such as CTX001 for beta thalassemia and sickle cell disease, are partnered projects. Given Vertex's solid drug-development track record, there's a good chance at least some of these treatments will reach pharmacy shelves.A final reason to be excited about Vertex is the company's cash-rich balance sheet. Sporting $8.24 billion in cash, cash equivalents, and marketable securities (and no debt), the company has ample capital to continue its research and perhaps even do some shopping of its own.With north of $15 per share in earnings forecast by Wall Street in 2023, Vertex has shown no signs of slowing down.","news_type":1},"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9029049226,"gmtCreate":1652708041765,"gmtModify":1676535145549,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>f","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>f","text":"$Apple(AAPL)$f","images":[{"img":"https://community-static.tradeup.com/news/253df2ae351deeee390a0fb13ea3865b","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9029049226","isVote":1,"tweetType":1,"viewCount":443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9029049837,"gmtCreate":1652708018529,"gmtModify":1676535145541,"author":{"id":"3581814406562580","authorId":"3581814406562580","name":"bhahab","avatar":"https://static.tigerbbs.com/da94be6bbb6d4ccc736167ee40fdfe71","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581814406562580","authorIdStr":"3581814406562580"},"themes":[],"htmlText":"G","listText":"G","text":"G","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9029049837","repostId":"2235835962","repostType":4,"repost":{"id":"2235835962","pubTimestamp":1652706172,"share":"https://ttm.financial/m/news/2235835962?lang=&edition=fundamental","pubTime":"2022-05-16 21:02","market":"us","language":"en","title":"2 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget","url":"https://stock-news.laohu8.com/highlight/detail?id=2235835962","media":"Motley Fool","summary":"Buying these stocks on the dip could result in big returns for investors.","content":"<html><head></head><body><p>The <b>S&amp;P 500</b> is off to a horrible start in 2022, falling more than 16% just over four months into the year. And the worst thing investors can do right about now is &#34;obsess&#34; about their investments and constantly check on stock prices. That&#39;s a surefire way to panic and make a knee-jerk decision that you regret later on.</p><p>A much safer strategy is to find some good deals, buy them, and leave those investments alone. A company with good fundamentals that has a bright future will do well over the long haul, regardless of what the markets do in the short term. A couple of growth stocks that are trading near their 52-week lows and can be tempting options to just buy and forget about include <b>Seagen</b> and <b>Alphabet</b>.</p><h2>1. Seagen</h2><p>Shares of healthcare company Seagen have fallen more than 20% since the start of the year. Although that&#39;s not disastrous, given how badly the markets have been performing, it&#39;s been enough of a drop to push Seagen down to a new 52-week low recently.</p><p>The good news is that Seagen&#39;s business isn&#39;t in bad shape. On the contrary, it can be an attractive pickup for long-term investors. It has some promising cancer medications in its portfolio, including Adcetris, which treats Hodgkin&#39;s lymphoma. Seagen anticipates that Adcetris will bring in up to $755 million in revenue this year, accounting for nearly half of the company&#39;s total product revenue.</p><p>But Seagen&#39;s business is broader than just <a href=\"https://laohu8.com/S/AONE.U\">one</a> drug, with bladder cancer drug Padcev and breast cancer medicine Tukysa projected to bring in up to $455 million and $335 million this year, respectively. Cervical cancer drug Tivdak is new, with the Food and Drug Administration approving it in September. And it could end up being a blockbuster, generating more than $1 billion in annual revenue for Seagen down the road; the company hasn&#39;t forecasted its contribution to the top line this year, but through the first three months of 2022, it generated over $11 million in sales.</p><p>Overall, Seagen forecasts that net product sales could top more than $1.5 billion and increase by 12% this year. While that isn&#39;t an astronomical growth rate, the company has trials ongoing to expand the indications for its existing products and potentially lead to more growth opportunities in the future. In total, management says that it has more than 17 pipeline programs that it is advancing in 2022.</p><p>Another positive for long-term investors is that while Seagen remains unprofitable today, the company&#39;s business is well funded. As of the end of March, the company had more than $1.9 billion in cash and short-term investments on its books. Last year, the company burned through $500 million in cash over the course of its day-to-day operating activities.</p><p>And so as long as Seagen&#39;s cash burn doesn&#39;t significantly worsen this year (and there&#39;s no reason to expect that it will), the business doesn&#39;t need to depend on frequent share offerings (i.e., dilution) to fund its growth. That can make the stock a relatively safe growth investment to hang on to for the long haul, and one that investors won&#39;t have to worry about.</p><h2>2. Alphabet</h2><p>Alphabet&#39;s stock has been nosediving this year, and the release of its latest earnings report last month didn&#39;t help matters either. The tech company&#39;s first-quarter performance fell short of analyst expectations, with both the top and bottom lines showing some weakness. In particular, advertising from YouTube was soft, with ad sales from the video platform coming in at $6.87 billion for the first three months of the year versus Wall Street estimates of $7.51 billion.</p><p>However, there&#39;s still plenty of growth ahead for the business. According to Technavio, online ad spending is projected to grow at a compounded annual growth rate of just under 11% until 2026. And in what researchers call a fragmented market, where few players (including Alphabet) dominate, the company stands to benefit from a lot of that long-term growth. An underwhelming performance in Alphabet&#39;s most recent quarterly earnings doesn&#39;t change the long-term trajectory of its business, which remains strong.</p><p>With shares of Alphabet down 20% so far this year, now could be an optimal time to buy the stock. Its price-to-earnings ratio of 21 looks like a steal for a business that is still growing revenue at a rate of 23%. Over the past couple of years, it hasn&#39;t been uncommon to see the stock trade at more than 30 times its trailing profits.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-16 21:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/05/16/2-cheap-growth-stocks-near-their-52-week-lows-to-b/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P 500 is off to a horrible start in 2022, falling more than 16% just over four months into the year. And the worst thing investors can do right about now is \"obsess\" about their investments and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/16/2-cheap-growth-stocks-near-their-52-week-lows-to-b/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOGL":"谷歌A","SGEN":"Seagen","GOOG":"谷歌"},"source_url":"https://www.fool.com/investing/2022/05/16/2-cheap-growth-stocks-near-their-52-week-lows-to-b/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2235835962","content_text":"The S&P 500 is off to a horrible start in 2022, falling more than 16% just over four months into the year. And the worst thing investors can do right about now is \"obsess\" about their investments and constantly check on stock prices. That's a surefire way to panic and make a knee-jerk decision that you regret later on.A much safer strategy is to find some good deals, buy them, and leave those investments alone. A company with good fundamentals that has a bright future will do well over the long haul, regardless of what the markets do in the short term. A couple of growth stocks that are trading near their 52-week lows and can be tempting options to just buy and forget about include Seagen and Alphabet.1. SeagenShares of healthcare company Seagen have fallen more than 20% since the start of the year. Although that's not disastrous, given how badly the markets have been performing, it's been enough of a drop to push Seagen down to a new 52-week low recently.The good news is that Seagen's business isn't in bad shape. On the contrary, it can be an attractive pickup for long-term investors. It has some promising cancer medications in its portfolio, including Adcetris, which treats Hodgkin's lymphoma. Seagen anticipates that Adcetris will bring in up to $755 million in revenue this year, accounting for nearly half of the company's total product revenue.But Seagen's business is broader than just one drug, with bladder cancer drug Padcev and breast cancer medicine Tukysa projected to bring in up to $455 million and $335 million this year, respectively. Cervical cancer drug Tivdak is new, with the Food and Drug Administration approving it in September. And it could end up being a blockbuster, generating more than $1 billion in annual revenue for Seagen down the road; the company hasn't forecasted its contribution to the top line this year, but through the first three months of 2022, it generated over $11 million in sales.Overall, Seagen forecasts that net product sales could top more than $1.5 billion and increase by 12% this year. While that isn't an astronomical growth rate, the company has trials ongoing to expand the indications for its existing products and potentially lead to more growth opportunities in the future. In total, management says that it has more than 17 pipeline programs that it is advancing in 2022.Another positive for long-term investors is that while Seagen remains unprofitable today, the company's business is well funded. As of the end of March, the company had more than $1.9 billion in cash and short-term investments on its books. Last year, the company burned through $500 million in cash over the course of its day-to-day operating activities.And so as long as Seagen's cash burn doesn't significantly worsen this year (and there's no reason to expect that it will), the business doesn't need to depend on frequent share offerings (i.e., dilution) to fund its growth. That can make the stock a relatively safe growth investment to hang on to for the long haul, and one that investors won't have to worry about.2. AlphabetAlphabet's stock has been nosediving this year, and the release of its latest earnings report last month didn't help matters either. The tech company's first-quarter performance fell short of analyst expectations, with both the top and bottom lines showing some weakness. In particular, advertising from YouTube was soft, with ad sales from the video platform coming in at $6.87 billion for the first three months of the year versus Wall Street estimates of $7.51 billion.However, there's still plenty of growth ahead for the business. According to Technavio, online ad spending is projected to grow at a compounded annual growth rate of just under 11% until 2026. And in what researchers call a fragmented market, where few players (including Alphabet) dominate, the company stands to benefit from a lot of that long-term growth. An underwhelming performance in Alphabet's most recent quarterly earnings doesn't change the long-term trajectory of its business, which remains strong.With shares of Alphabet down 20% so far this year, now could be an optimal time to buy the stock. Its price-to-earnings ratio of 21 looks like a steal for a business that is still growing revenue at a rate of 23%. Over the past couple of years, it hasn't been uncommon to see the stock trade at more than 30 times its trailing profits.","news_type":1},"isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}